Cours NovAccess Global Inc. Other OTC
Actions
XSNX
US67001N1072
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 2,17 M 1,98 M |
---|---|---|---|---|---|
Résultat net 2022 | -1 M -911 k | Résultat net 2023 | -4 M -3,64 M | VE / CA 2022 | - |
Dette nette 2022 | 1,41 M 1,29 M | Dette nette 2023 | 2,36 M 2,15 M | VE / CA 2023 | - |
PER 2022 |
-1,16
x | PER 2023 |
-0,43
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 34,82% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 56 | 15/10/20 | |
Neil Laird
DFI | Director of Finance/CFO | 70 | 10/09/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 56 | 15/10/20 | |
Jason Anderson
BRD | Director/Board Member | 50 | 18/03/22 |
John Cassarini
CHM | Chairman | 57 | 14/03/22 |
Varia. 1 janv. | Capi. | |
---|---|---|
+0,67% | 42,4 Md | |
+46,11% | 40,04 Md | |
-6,20% | 28,31 Md | |
+6,55% | 24,94 Md | |
-21,66% | 18,96 Md | |
+29,96% | 12,3 Md | |
-1,57% | 11,95 Md | |
+16,03% | 11,32 Md | |
-4,80% | 11,55 Md |